GB9414624D0 - Novel method - Google Patents

Novel method

Info

Publication number
GB9414624D0
GB9414624D0 GB9414624A GB9414624A GB9414624D0 GB 9414624 D0 GB9414624 D0 GB 9414624D0 GB 9414624 A GB9414624 A GB 9414624A GB 9414624 A GB9414624 A GB 9414624A GB 9414624 D0 GB9414624 D0 GB 9414624D0
Authority
GB
United Kingdom
Prior art keywords
novel method
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9414624A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROYSTON MAUREEN C
SmithKline Beecham Ltd
University of South Florida
Original Assignee
ROYSTON MAUREEN C
SmithKline Beecham Ltd
University of South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROYSTON MAUREEN C, SmithKline Beecham Ltd, University of South Florida filed Critical ROYSTON MAUREEN C
Priority to GB9414624A priority Critical patent/GB9414624D0/en
Publication of GB9414624D0 publication Critical patent/GB9414624D0/en
Priority to AU31142/95A priority patent/AU3114295A/en
Priority to PCT/EP1995/002823 priority patent/WO1996002670A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB9414624A 1994-07-20 1994-07-20 Novel method Pending GB9414624D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB9414624A GB9414624D0 (en) 1994-07-20 1994-07-20 Novel method
AU31142/95A AU3114295A (en) 1994-07-20 1995-07-12 Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases
PCT/EP1995/002823 WO1996002670A1 (en) 1994-07-20 1995-07-12 Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9414624A GB9414624D0 (en) 1994-07-20 1994-07-20 Novel method

Publications (1)

Publication Number Publication Date
GB9414624D0 true GB9414624D0 (en) 1994-09-07

Family

ID=10758607

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9414624A Pending GB9414624D0 (en) 1994-07-20 1994-07-20 Novel method

Country Status (3)

Country Link
AU (1) AU3114295A (en)
GB (1) GB9414624D0 (en)
WO (1) WO1996002670A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408465D0 (en) * 1994-04-27 1994-06-22 Univ Mcgill Apolipoprotein e polymorphism & treatment of alzheimer's disease
US7049078B2 (en) 1994-04-27 2006-05-23 Judés Poirier Apolipoprotein E polymorphism and treatment of alzheimer's disease
US6022683A (en) * 1996-12-16 2000-02-08 Nova Molecular Inc. Methods for assessing the prognosis of a patient with a neurodegenerative disease
WO1997016458A1 (en) * 1995-11-01 1997-05-09 Kos Pharmaceuticals, Inc. Apolipoprotein e2 and treatment of alzheimer's disease
AT404993B (en) * 1997-01-13 1999-04-26 Immuno Ag METHOD FOR DETERMINING A PROTEIN WITH A MUTATION
WO2000020634A1 (en) 1998-10-01 2000-04-13 Nova Molecular, Inc. Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele
US11957713B2 (en) 2016-10-14 2024-04-16 Children's Medical Center Corporation Compositions and methods for treating diseases and disorders of the central nervous system
WO2018136435A1 (en) 2017-01-17 2018-07-26 Children's Medical Center Corporation Compositions and methods for treating lysosomal storage diseases and disorders
EP3571310A4 (en) 2017-01-17 2020-12-16 Children's Medical Center Corporation Compositions and methods for diagnosing and treating peroxisomal diseases
CN114555100A (en) * 2019-10-01 2022-05-27 儿童医疗中心有限公司 Compositions and methods for treating alzheimer's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0625212B1 (en) * 1992-10-13 2004-03-24 Duke University Methods of detecting alzheimer's disease
AU681434B2 (en) * 1993-08-31 1997-08-28 Duke University Methods and compositions for binding TAU and MAP2c proteins
CA2111503A1 (en) * 1993-12-15 1995-06-16 Mcgill University Apolipoprotein e polymorphism and alzheimer's disease

Also Published As

Publication number Publication date
WO1996002670A1 (en) 1996-02-01
AU3114295A (en) 1996-02-16

Similar Documents

Publication Publication Date Title
GB9600464D0 (en) Novel method
GB9521447D0 (en) Method
AP9500717A0 (en) Novel method
GB2289946B (en) Method
GB9414624D0 (en) Novel method
GB9417135D0 (en) Method
GB9415073D0 (en) Novel method
GB9423905D0 (en) Novel method
GB9609722D0 (en) Novel method
GB9604465D0 (en) Novel method
GB9424723D0 (en) Method
GB9401566D0 (en) Method
ZA951002B (en) Novel method
GB9426019D0 (en) Novel method
GB9402623D0 (en) Novel method
GB9406789D0 (en) Novel method
GB9410214D0 (en) Novel method
GB9421473D0 (en) Novel method
GB9412320D0 (en) Method
GB9417136D0 (en) Method
GB9414770D0 (en) Method
GB9421234D0 (en) Method
GB9401106D0 (en) Method
GB9403193D0 (en) Method
GB9403192D0 (en) Method